Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 403, Issue 2, 2012, Pages 483-493

  Mal, Mainak ^a   Koh, Poh Koon ^b   Cheah, Peh Yean ^b   Chan, Eric Chun Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Colorectal cancer; Endogenous metabolites; Global metabolic profiling; Metabonomics; Two dimensional gas chromatography mass spectrometry

Indexed keywords

AGILENT; BILE ACID; BIOCHEMICAL PROCESS; COLORECTAL CANCER; FUSED SILICA CAPILLARY COLUMNS; KREBS CYCLE; METABOLIC PATHWAYS; METABOLIC PROFILING; METABONOMICS; MOLECULAR INSIGHTS; NORMAL TISSUE; NUCLEOTIDE METABOLISM; PEGASUS; SPACE COVERAGE; STEROID BIOSYNTHESIS; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GAS CHROMATOGRAPHY;

AMINO ACIDS; BIOCHEMISTRY; BIOSYNTHESIS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; TISSUE;

DISEASES;

AGED; ARTICLE; CANCER STAGING; CHEMISTRY; COLORECTAL TUMOR; EVALUATION; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOMICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 84861235132     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-5870-5     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2008) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide. IARC, Lyon, France. Available from: http://globocan. iarc.fr
2. Tey J, Baggarley S, Lee KM (2008) Cancer care in Singapore. Biomed Imaging Interv J 4:e38
3. Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM, Ong CN, Cheah PY, Eu KW, Hew CL (2006) Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics 5(6):1119-1130 (Pubitemid 43985935)
4. Longley DB, Allen WL, Johnston PG (2006) Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta 1766(2):184-196
5. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11):1181-1189
6. Fiehn O (2001) Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genom 2(3):155-168 (Pubitemid 32590962)
7. Dunn WB, Bailey NJ, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130(5):606-625 (Pubitemid 40685888)
8. Lindon JC, Nicholson JK, Holmes E (2007) The handbook of metabonomics and metabolomics. Elsevier, The Netherlands
9. Adahchour M, Beens J, Brinkman UA (2008) Recent developments in the application of comprehensive two-dimensional gas chromatography. J Chromatogr A 1186(1-2):67-108
10. Beens J, Adahchour M, Vreuls RJ, van Altena K, Brinkman UA (2001) Simple, non-moving modulation interface for comprehensive two-dimensional gas chromatography. J Chromatogr A 919:127-132 (Pubitemid 32522411)
11. Khummueng W, Harynuk J, Marriott PJ (2006) Modulation ratio in comprehensive two-dimensional gas chromatography. Anal Chem 78(13):4578-4587
12. Dimandja JM, Clouden GC, Colon I, Focant JF, Cabey WV, Parry RC (2003) Standardized test mixture for the characterization of comprehensive two-dimensional gas chromatography columns: the Phillips mix. J Chromatogr A 1019(1-2):261-272 (Pubitemid 37329913)
13. Ryan D, Morrison P, Marriott P (2005) Orthogonality considerations in comprehensive two-dimensional gas chromatography. J Chromatogr A 1071(1-2):47-53 (Pubitemid 40461756)
14. Koek MM, Muilwijk B, van Stee LL, Hankemeier T (2008) Higher mass loadability in comprehensive two-dimensional gas chromatography-mass spectrometry for improved analytical performance in metabolomics analysis. J Chromatogr A 1186(1-2):420-429
15. Mohler RE, Dombek KM, Hoggard JC, Young ET, Synovec RE (2006) Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells. Anal Chem 78(8):2700-2709
16. Pasikanti KK, Ho PC, Chan EC (2008) Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 871(2):202-211
17. Sinha AE, Hope JL, Prazen BJ, Nilsson EJ, Jack RM, Synovec RE (2004) Algorithm for locating analytes of interest based on mass spectral similarity in GC×GC-TOF-MS data: analysis of metabolites in human infant urine. J Chromatogr A 1058(1-2):209-215 (Pubitemid 39487222)
18. Welthagen W, Shellie RA, Spranger J, Ristow M, Zimmermann R (2005) Comprehensive two dimensional gas chromatography-time of flight mass spectrometry (GC×GC-TOF) for high resolution metabolomics: biomarker discovery on spleen tissue extracts of obese NZO compared to lean C57BL/6 mice. Metabolomics 1:57-65
19. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8(1):352-361
20. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O (2008) Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Canc 7:72
21. Ong ES, Zou L, Li S, Cheah PY, Eu KW, Ong CN (2010) Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics. doi:10.1074/mcp. M900551-MCP200
22. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69(11):4918-4925
23. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37(Database issue):D603-D610
24. Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27-30 (Pubitemid 30047706)
25. Griffin JL, Shockcor JP (2004) Metabolic profiles of cancer cells. Nat Rev Cancer 4:551-561 (Pubitemid 38868624)
26. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
27. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, Beroukhim R, Stephanopoulos G, Ligon AH, Meyerson M, Richardson AL, Chin L, Wagner G, Asara JM, Brugge JS, Cantley LC, Vander Heiden MG (2011) Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43(9):869-874
28. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, Chen WW, Barrett FG, Stransky N, Tsun ZY, Cowley GS, Barretina J, Kalaany NY, Hsu PP, Ottina K, Chan AM, Yuan B, Garraway LA, Root DE, Mino-Kenudson M, Brachtel EF, Driggers EM, Sabatini DM (2011) Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476(7360):346-350
29. Bismut H, Caron M, Coudray-Lucas C, Capeau J (1995) Glucose contribution to nucleic acid base synthesis in proliferating hepatoma cells: a glycine-biosynthesis-mediated pathway. Biochem J 308(Pt 3):761-767
30. Snell K, Natsumeda Y, Weber G (1987) The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture. Biochem J 245(2):609-612
31. Kit S (1955) The biosynthesis of free glycine and serine by tumors. Cancer Res 15(11):715-718
32. Fu TF, Rife JP, Schirch V (2001) The role of serine hydroxymethyltransferase isozymes in one-carbon metabolism in MCF-7 cells as determined by (13) C NMR. Arch Biochem Biophys 393(1):42-50 (Pubitemid 32808357)
33. Lipkin M, Yang K, Edelmann W, Xue L, Fan K, Risio M, Newmark H, Kucherlapati R (1999) Preclinical mouse models for cancer chemoprevention studies. Ann N YAcad Sci 889:14-19 (Pubitemid 30040421)
34. Hentosh P, Yuh SH, Elson CE, Peffley DM (2001) Sterolindependent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol Carcinog 32(3):154-166 (Pubitemid 33055004)
35. Wachtershauser A, Akoglu B, Stein J (2001) HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22(7):1061-1067 (Pubitemid 32633605)
36. Rao CV, Newmark HL, Reddy BS (1998) Chemopreventive effect of squalene on colon cancer. Carcinogenesis 19(2):287-290 (Pubitemid 28376710)
37. Garber K (2006) Energy deregulation: licensing tumors to grow. Science 312(5777):1158-1159
38. Reddy BS (1986) Amount and type of dietary fat and colon cancer: animal model studies. Prog Clin Biol Res 222:295-309
39. Reddy BS (1992) Dietary fat and colon cancer: animal model studies. Lipids 27(10):807-813
40. Burg MB, Ferraris JD (2008) Intracellular organic osmolytes: function and regulation. J Biol Chem 283(12):7309-7313
41. Baker H, Frank O, Chen T, Feingold S, DeAngelis B, Baker ER (1981) Elevated vitamin levels in colon adenocarcinoma as compared with metastatic liver adenocarcinoma from colon primary and normal adjacent tissue. Cancer 47(12):2883-2886 (Pubitemid 11066884)
42. Bosco MC, Rapisarda A, Massazza S, Melillo G, Young H, Varesio L (2000) The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages. J Immunol 164(6):3283-3291 (Pubitemid 30148992)
43. Kashfi K, Rigas B (2005) Is COX-2 a 'collateral' target in cancer prevention? Biochem Soc Trans 33(Pt 4):724-727 (Pubitemid 41160850)
44. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55(17):3785-3789
45. Shureiqi I, Lippman SM (2001) Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61(17):6307-6312 (Pubitemid 32783228)
46. Smith WL (1992) Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263(2 Pt 2):F181-F191
47. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89(12):2637-2645 (Pubitemid 32011609)
48. Soumaoro LT, Iida S, Uetake H, Ishiguro M, Takagi Y, Higuchi T, Yasuno M, Enomoto M, Sugihara K (2006) Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol 12(39):6355-6360 (Pubitemid 44712419)